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Abstract 27 
Consistent reports indicate that hypertension is a particularly common finding in black 28 
populations. Hypertension occurs at younger ages and is often more severe in terms of 29 
blood pressure levels and organ damage than in whites, resulting in a higher incidence of 30 
cardiovascular disease and mortality. This review provides an outline of recent advances in 31 
the pathophysiological understanding of blood pressure elevation and the consequences 32 
thereof in black populations in Africa. This is set against the backdrop of populations 33 
undergoing demanding and rapid demographic transition, where infection with the Human 34 
Immunodeficiency Virus predominates, and where under and over-nutrition coexist. 35 
Collectively, recent findings from Africa illustrate an increased lifetime risk to hypertension 36 
from foetal life onwards. From young ages black populations display early endothelial 37 
dysfunction, increased vascular tone and reactivity, microvascular structural adaptions, as 38 
well as increased aortic stiffness resulting in elevated central and brachial blood pressures 39 
during the day and night, when compared to whites. Together with knowledge on the 40 
contributions of sympathetic activation and abnormal renal sodium handling, these 41 
pathophysiological adaptations result in subclinical and clinical organ damage at younger 42 
ages. 43 
This overall enhanced understanding on the determinants of blood pressure elevation in 44 
blacks encourages (a) novel approaches to assess and manage hypertension in Africa 45 
better, (b) further scientific discovery to develop more effective prevention and treatment 46 
strategies, and (c) policymakers and health advocates to collectively contribute in creating 47 
health-promoting environments in Africa.  48 
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Introduction 49 
A recent global analysis in 19.1 million participants indicated that blood pressure has on 50 
average decreased worldwide since 1975. However, during the past four decades, the 51 
highest blood pressures shifted from high income countries to the low income countries in 52 
sub-Saharan Africa.1 Unfortunately, current practices to detect and treat hypertension in 53 
Africa are overwhelmingly ineffective, evidenced by appallingly low awareness (27%), 54 
treatment (18%) and control rates (7%).2 These failing practices are possibly due to weak 55 
health systems,3 education and current antihypertensive treatment not being as effective in 56 
black populations.4 57 
A review paper in 2005 by Opie and Seedat on hypertension in sub-Saharan Africa 58 
described the classic salt-sensitive volume-overload low plasma renin phenotype.5 But they 59 
also highlighted that further studies in Africa are urgently needed, as this population could 60 
differ genetically and environmentally from African Americans.5 The Hypertension in Africa 61 
Research Team (HART) and other research centres throughout Africa have taken significant 62 
strides forward over the past decade in improving our understanding of hypertension 63 
development in Africa, beyond salt-sensitive volume-loading hypertension. In this review we 64 
will therefore provide an outline of recent advances in deciphering contributors towards 65 
blood pressure elevation and the consequences thereof in Africans. This is set against the 66 
backdrop of black populations simultaneously undergoing nutritional, epidemiological and 67 
demographic transition;6 where infection with the Human Immunodeficiency Virus (HIV) 68 
predominates;7 where famine, fertility rates and life expectancy fluctuate; and under- and 69 
over-nutrition coexist. Therefore, to counteract the rapidly increasing hypertension 70 
prevalence rates1 within a vast economically-driven continent, we urgently need a better 71 
pathophysiological understanding of hypertension in blacks to reach novel and alternative 72 
approaches in preventing, managing and treating hypertension in Africa. 73 
  74 
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Health behaviours and lifestyle exposures 75 
Lifestyle and health behaviours remain the most important preventable cardiovascular risk 76 
factors, and this is also the case within Africa. With recent dramatic demographic transitions 77 
on the continent, adverse health behaviours are expected to escalate, with strong trends 78 
already evident.  79 
An important aspect that was generally overlooked in the past, is the concept of lifetime risk 80 
applicable to the entire population from conception.8 Globally evidence indicates that the 81 
development of subclinical and sometimes clinical cardiovascular disease (CVD) results 82 
from early programming and lifetime exposure to cardiovascular risk factors.8 It is likely that 83 
lifestyle exposures during foetal life and childhood promote the development of vascular 84 
changes that launch the individual along the trajectory of so-called early vascular aging, in 85 
which an accumulation of vascular damage occurs already in early adulthood.8 Recent 86 
evidence from the longitudinal ‘Birth to Twenty’ study of urban black South African mothers 87 
and offspring shows that low birth-weight, combined with rapid weight gain in infancy, 88 
already produce elevations in blood pressure.9 While these changes translate into increased 89 
adiposity and blood pressure later in life,10 there appears to be a protective effect of upward 90 
socioeconomic status (SES) mobility on systolic blood pressure.11 These findings 91 
underscore the need for further research into lifetime risk and exposure to risk factors in 92 
Africa. 93 
The nutrition transition 94 
Advances in food technology have allowed the production of highly palatable, energy dense, 95 
low cost, ultra-processed foods, snacks and beverages that are increasingly appearing 96 
within the food supply in middle- and low-income countries.12,13 In Africa consumers are 97 
attracted to these products by their price, convenience, availability and taste, often as a 98 
result of heavy product marketing by companies, who in turn are attracted by the potential 99 
profits from the region alongside trade and investment liberalisation policies.14 As 100 
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consumption of ultra-processed foods (and fat, sugar and salt) increases, consumption of 101 
more traditional and nutritionally adequate diets is reduced,15 especially in poorer 102 
populations driven by the lower cost-per-kilojoule of processed alternatives.16 While changes 103 
are most pronounced in urban populations, rural populations are not immune to the nutrition 104 
transition.14 This was clearly demonstrated in rural areas from the Prospective Urban Rural 105 
Epidemiology (PURE) study in South Africa where added sugar intake more than doubled 106 
from 2005-2010.17 The net effect is reduced intake of nutrient dense foods such as fruits, 107 
vegetables, legumes and coarse grains6 with associated reductions in nutrients such as 108 
dietary fibre and potassium, concomitant with increased sodium-to-potassium ratio of the 109 
diet.18 110 
Obesity 111 
The nutrition transition not only affects blood pressure, but also obesity rates. Within sub-112 
Saharan Africa, individuals living in urban areas are at increased risk of being overweight or 113 
obese,19 with the largest increases in obesity observed in urban women with low SES.20,21 114 
While physical inactivity inevitably plays a role in this, the nutrition transition also influences 115 
obesity levels in both urban and rural regions.17 The resultant overall obesity, but particularly 116 
abdominal obesity, was found to predict 5-year cardiovascular and metabolic risk in black 117 
South Africans.22 Obesity and hypertension are causally related,23 and also integrated with 118 
metabolic disturbances.24 Mechanistically we have also highlighted the contribution of 119 
obesity-related sympathetic over activity25 and adipocytokines to elevated blood pressure in 120 
black populations.26 When viewed in combination with the recent dietary and physical activity 121 
changes, plus the enhanced susceptibility to CVD proposed by the foetal origins of adult 122 
disease hypothesis,9,10 the rapid escalation of hypertension in African countries is perhaps 123 
not surprising. 124 
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Physical activity 126 
The benefits of regular physical activity for blood pressure control are well established and 127 
recommended as part of antihypertensive therapy.27 However, in South Africa, 49% of 128 
women and 45% of men are estimated to be physically inactive, and these levels far exceed 129 
the estimated average (18%) for the African continent.28 Alarmingly these rates were also 130 
reported in South African children, where 50% of school children did not meet the daily 131 
recommended physical activity levels.29 Apart from elevated blood pressure linking to 132 
physical inactivity, an additional consequence is increases in adiposity.20 With reports 133 
indicating that rural populations have higher activity levels than urban dwellers, largely due 134 
to increased walking, cycling and more physically demanding jobs,30 the far-reaching 135 
consequences of rapid urbanisation for hypertension development become even clearer. 136 
Alcohol and tobacco use 137 
In an initial review of hypertension in sub-Saharan Africa in 2005,5 little mention was made of 138 
smoking and alcohol in the development of hypertension-related CVDs, with alcohol use 139 
being discussed primarily as a risk factor in high income groups. In the intervening years, 140 
and with economic transition, there has been a shift on the continent in smoking and alcohol 141 
consumption. Many African countries are finding tobacco products more affordable due to 142 
increases in income and purchasing power, with an estimated 20-50% of adult men smoking 143 
in Sierra Leone, Lesotho, the Seychelles, Burkina Faso, Côte d'Ivoire, Gabon, Gambia, Mali, 144 
Mauritania, Mauritius, Tanzania, Zambia and Zimbabwe, and tobacco use increasing in 145 
African youth.31,32 Taxes have had some success in reducing smoking prevalence in South 146 
Africa,33 although rates are still high, and worryingly 24% and 19% of 13-15 year old boys 147 
and girls respectively, are estimated as using tobacco.32 148 
Within South Africa, alcohol is the most commonly misused substance with high levels of 149 
reported binge drinking behaviour especially in youth,34 and excess alcohol use associated 150 
with hypertension.35 We found that South African adults reporting alcohol use had a 30% 151 
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increased risk of developing hypertension over five years.36 In Uganda, alcohol use was 152 
associated with a 64% risk,37 and in Angola with a 40% increased risk of developing 153 
hypertension.38 As we and others have demonstrated, alcohol abuse is implicated in arterial 154 
stiffness,39 metabolic disturbances,40 blood pressure elevation over time,35 as well as 155 
cardiovascular mortality.36 As such, it is crucial that more effective strategies be put in place 156 
to not only delay the onset of alcohol use, but to significantly change behaviours and societal 157 
acceptability of excessive alcohol use. 158 
Salt intake 159 
The Global Burden of Disease Study lists diets high in sodium as one of the ten largest 160 
contributors to disability adjusted life years, primarily through elevated systolic blood 161 
pressure.41 A recent systematic review examining salt intakes in sub-Saharan Africa and 162 
including data from 13 countries suggested that over 80% of adult populations consume 163 
more than the World Health Organization recommended 5g salt or 2g sodium each day42 164 
with bread being a major contributor to salt intake.43 Within South Africa, high salt intakes 165 
are shown consistently across different age, gender and ethnic groups.18 There is some 166 
suggestion that black populations have a greater blood pressure benefit from salt reduction 167 
when compared to other ethnic groups, although these differences may be clinically 168 
insignificant44 and related to socioeconomic disparity rather than ethnicity.45 Salt reduction 169 
initiatives in the region have consistently shown small but significant reductions in blood 170 
pressure.46 South Africa appears to lead the way with implementation of legislation in June 171 
2016 mandating maximum sodium levels in a comprehensive range of processed foods with 172 
further reductions planned for 2019. Estimates suggest considerable economic and health 173 
benefits of such a policy,47,48 whereas ongoing studies will determine whether the legislation 174 
will have the desirable effects on population salt intake and blood pressures.49 175 
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Socio-economic status and health disparities 177 
The African continent continues to experience some of the world’s highest levels of 178 
economic, health, gender and education inequity.50,51 Research in Africa confirms findings 179 
that the association between socioeconomic disparity and hypertension cannot only be 180 
explained by traditional risk factors such as obesity, smoking, alcohol use and physical 181 
activity.52 Much research on this topic has been conducted in African Americans, with less 182 
evidence available for blacks living within Africa. However, cross-sectional52,53 and 183 
longitudinal54,55 associations between socioeconomic status, emotional distress and 184 
hypertension are observed in Africa. 185 
Blood pressure measurement and profiles 186 
A systematic review on the burden of undiagnosed hypertension in Africa highlights that of 187 
those with hypertension, only 1 in 4 is aware of their hypertensive status.2 On this continent 188 
economic challenges and weak health systems barely allow for adequate clinic blood 189 
pressure assessment. But a recent study in Nigeria demonstrated that it would greatly 190 
benefit African countries to increase access to quality healthcare, as this was associated 191 
with a significant longer-term reduction in blood pressure in subjects at highest risk of CVD.3 192 
Also, in Africa conventional office blood pressure measurement remains by far the most 193 
common method to determine blood pressure and manage hypertension. The 194 
recommendation for out-of-office measurements may therefore seem absurd. But it is only 195 
by reviewing 24-hour blood pressure profiles that specific features such as white-coat 196 
hypertension, masked hypertension and nocturnal dipping status can be detected. When 197 
viewing ambulatory blood pressure profiles in similarly-aged black and white South African 198 
school teachers from the Sympathetic activity and Ambulatory Blood Pressure in Africans 199 
(SABPA) study (Figure 1), it is clear that both black men and women exert significantly 200 
higher 24-hour, daytime, and nighttime systolic and diastolic blood pressures56 (as well as 201 
heart rate25). Masked hypertension, referring to in-office normotension but out-of-office 202 
hypertension, carries similar cardiovascular risk to hypertension.57 We and others have 203 
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shown that masked hypertension is common in African populations,57 with prevalence rates 204 
of 18% in healthy 20-30 year old black adults,58 41% of low-income South African adults 205 
(mean age 39 ± 9.7 years),59 and 14.4% of Nigerians.60 These findings translate to a gross 206 
underestimation in the prevalence of hypertension in Africa, and encourage different 207 
approaches to determine out-of-office blood pressure (such as home monitoring), potentially 208 
in select populations. 209 
Pathophysiological mechanisms of blood pressure elevation 210 
Psychosocial stress, sympathetic nerve activity and neurogenic hypertension 211 
An urban lifestyle is characterised by demanding stress situations which may involve job 212 
stress, personal changes, marital problems, cultural differences and various others.53,61 The 213 
integrity of the physiological stress pathway, namely the hypothalamic-pituitary-adrenal 214 
cortex axis, is essential for an adequate defence response and cortisol secretion to 215 
determine the appropriate behavioural response to stress.62 Excessive, prolonged or 216 
inadequate cortisol responses will impair an individual’s adaptation to stress, with either up- 217 
or down-regulation in hypothalamic-pituitary-adrenal cortex axis activity.63,64 218 
Neurogenic hypertension refers to disturbed central neural control of subcortical areas 219 
regulating emotion, which may increase hypertension risk.65 Indeed, poor mental health was 220 
related to norepinephrine spill-over66 and essential hypertension in sub-Saharan African 221 
cohorts.52,53,65,67 While there is no generally accepted method of evaluating overall central 222 
and peripheral sympathetic nervous system activity,68 the probability of emotional stress 223 
preceding sympathetic activation and risk for hypertension has not been acknowledged. 224 
However, both acute and chronic stress responses are related to target organ damage in 225 
black adults,61,69 with accentuated responses in men coping defensively with social stress.65 226 
In comparison to whites, the responses to both acute and chronic stress (Figure 2) in black 227 
adults showed a profile of sympathetic activation and central neuro-endocrine control. Acute 228 
neural control demonstrated increased vascular responsiveness,69,70 myocardial ischemia54 229 
and attenuated cortisol responses.64 Chronic neuro-endocrine control revealed chronic 230 
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depression,71 desensitised 24h heart rate variability and 24h urinary 231 
norephinephrine:creatinine responses.54 Chronic emotional stress and accompanying blood 232 
pressure increases to alleviate perfusion deficits,71 may exemplify neurogenic hypertension. 233 
Salt-sensitivity and volume-loading hypertension 234 
The suppression of the renin-angiotensin-aldosterone system (RAAS) due to volume-loading 235 
hypertension is common in Africans, and is evident from childhood.72-75 This phenotype 236 
guided Clinical Practice Guidelines for antihypertensive treatment in black populations to 237 
avoid medication directed towards the RAAS as first line treatment.4 Lower plasma renin 238 
activity and aldosterone were reported in normotensive76 and hypertensive77 black South 239 
Africans when compared to whites. We have also confirmed suppressed angiotensin I and II 240 
in black hypertensives compared to whites.78 This phenotype is characterised by elevated 241 
blood pressure, higher aldosterone-to-renin ratio (ARR), or low renin and low 242 
aldosterone.74,77,79 The ARR modifies the relationship between blood pressure and salt 243 
intake in Africans and African Americans, pointing to a role in salt-sensitive low renin 244 
hypertension.80,81 ARR relates to left ventricular hypertrophy in black children and adults, 245 
despite blacks having lower aldosterone and renin compared to whites.75,82 We also found 246 
that low plasma renin and renin reactivity to an acute stressor associated with markers of 247 
end-organ damage, such as urinary albumin excretion and carotid wall thickness, in 248 
blacks.83,84 Genetic polymorphisms in Africans confirm that altered renal sodium handling 249 
has a potent role in the development of salt-sensitive, low renin hypertension.79,85,86 Sodium 250 
retention and volume expansion remain some of the key role players in the development of 251 
hypertension in blacks. 252 
Arterial structure and function 253 
Within the concept of early vascular aging reside several pathophysiological mechanisms 254 
affecting the arterial wall – including in particular the endothelium, vascular smooth muscle 255 
cells and the extracellular matrix. With hypertension development these changes occur from 256 
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the microvasculature to the large conduit vessels. A brief overview is provided on 257 
observations in black populations. 258 
• Endothelial function 259 
One of the haemodynamic observations in sub-Saharan black adults,24,69 children87 and 260 
adult African Americans,88 is a higher vascular resistance compared to whites. Vascular tone 261 
and the regulation thereof depend largely on endothelial function.89 In Americans, black race 262 
was associated with digital artery endothelial dysfunction in men and women undergoing 263 
assessment of digital pulse amplitude response to forearm occlusion-induced hyperaemia.90 264 
In healthy African Americans without known CVD risk factors, Ozkor et al.91 investigated 265 
differences in vascular nitric oxide (NO) and endothelium derived hyperpolarising factor 266 
(EDHF) bioavailability. EDHF seemed preserved but NO bioavailability and sensitivity 267 
reduced in the vasculature in blacks compared to whites. Our findings in black South 268 
Africans with low SES support this, indicating blacks having lower serum L-arginine (a 269 
substrate for NO synthesis) than whites.92 Recent data also point to a balance between NO 270 
bioavailability and creatine kinase, where both the NO and creatine kinase systems share a 271 
common precursor in L-arginine.93 Creatine kinase was found to predict blood pressure in 272 
the general population, and also predicted the failure of antihypertensive therapy.94 On 273 
balance, we have found in black school teachers with a higher SES, an elevated NO 274 
synthesis capacity as reflected by higher L-arginine and lower asymmetric 275 
dimethylarginine.95 However, the increased oxidative stress and an up-regulated redox 276 
system observed in black teachers10,11 could counteract NO bio-availability. Furthermore, we 277 
found no link between creatine kinase and blood pressure or vascular resistance in these 278 
black teachers.96 Due to the complexities of physiological systems involved in NO 279 
bioavailability, further research in larger populations including different levels of SES, are 280 
needed to clarify the above findings. 281 
 282 
 283 
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• Oxidative stress and inflammation 284 
Both inflammation and oxidative stress play a pivotal role in the development of endothelial 285 
dysfunction by exerting pro-inflammatory actions and reducing NO bio-availability.97 286 
Oxidative stress is defined as an imbalance between oxidants and antioxidants in favour of 287 
oxidants, and may lead to a disruption in redox signalling and macromolecule damage.98 288 
Oxidative stress is closely related to various processes involved in the development of 289 
hypertension. Our studies in black South Africans found that increased oxidative stress 290 
relates to elevated blood pressure,99,100 subclinical atherosclerosis100,101 and arterial 291 
stiffness.99,102 Oxidative stress was also linked to various biological processes related to 292 
vascular tone,103 angiogenesis104 and haemostasis105 in blacks. Taken together, these 293 
findings suggest that oxidative stress plays a role in early vascular changes in blacks who 294 
are prone to the development of CVD. In this regard the glutathione system and especially 295 
the regulation of key enzymes such as glutathione peroxidase and glutathione reductase are 296 
important role players.100,101,103,104 But oxidative stress should not be viewed in isolation, as 297 
there seems to be a strong, two-way link between oxidative stress and inflammation, 298 
suggesting that oxidative stress may amplify the inflammatory process. In turn a sustained 299 
inflammatory response may lead to the overproduction of reactive oxygen species.106 We 300 
found low-grade inflammation to be more common in black than white South 301 
Africans,39,107,108 and that it was influenced by modifiable risk factors such as obesity, alcohol 302 
and tobacco use.107,109,110 Inflammatory markers were higher and increased also more 303 
prominently in black South Africans that developed hypertension over five years.111 Our 304 
findings thus support the notion of hypertension being an inflammatory disease.97 This 305 
concept is further strengthened by our finding that higher levels of inflammatory markers 306 
predicted both cardiovascular and all-cause mortality in Africans.112 307 
• The microvasculature 308 
Hypertension is closely related to microvascular structural and functional changes of target 309 
organs, in particular those with high perfusion rates such as the heart, kidneys and brain.113 310 
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These changes include vasoconstriction, rarefaction, reduced vasodilatory reserve and in 311 
large arterioles, changes in wall-to-lumen ratio.113,114 The retina represents a unique site 312 
whereby direct visualisation of early hypertension-related microvascular changes can be 313 
observed.115 In the retinal microvasculature, small artery narrowing is related to hypertension 314 
and risk of incident hypertension, whereas vein widening related to atherosclerosis, 315 
atherosclerotic risk factors, risk of incident hypertension and independently predicted 316 
stroke.114,116-118 In 20-30 year old healthy blacks and whites from the African Prospective 317 
study on the Early Detection and Identification of Cardiovascular disease and Hypertension, 318 
(African-PREDICT), we found black ethnicity to be independently associated with retinal 319 
artery narrowing.119 In the older participants of the SABPA study, black teachers who 320 
displayed a worse cardiovascular profile, presented a smaller retinal arterio-venous ratio, 321 
with wider veins when compared to their white counterparts.120 Microvascular deterioration 322 
reflected by retinal vein widening in blacks was associated with a lack of nocturnal blood 323 
pressure dipping121 as well as chronic depression symptoms.71 In another microvascular bed 324 
healthy black South Africans were shown to display attenuated endothelium-independent 325 
microvascular function when compared to whites, suggesting possible differences in 326 
microvascular smooth muscle function.122 327 
• Arterial stiffness 328 
Carotid-femoral pulse wave velocity, the most accepted non-invasive method of determining 329 
arterial stiffness, is an independent predictor for all-cause and cardiovascular mortality, 330 
coronary events, as well as strokes, type 2 diabetes, and end-stage renal disease.123 331 
Reports from both African Americans and black South Africans confirm increased arterial 332 
stiffness in black compared to white populations.124,125 It is as yet unclear whether increased 333 
stiffness in blacks is due to genetic predisposition, early life exposures or social disparities. 334 
Where early reports are limited in establishing a link between arterial stiffness and genetic 335 
predisposition,126 we have found increased arterial stiffness in blacks with low SES 336 
compared to whites with high SES.124 To counter SES, we included 6-8 year old black and 337 
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white boys from similar schools, and found increased arterial stiffness in the carotid-radial, 338 
carotid-dorsalis pedis and carotid-femoral regions, along with elevated diastolic pressure and 339 
peripheral vascular resistance in black boys.127 In the African-PREDICT study we excluded 340 
hypertensives, but included healthy black and white adults (20-30 years) with normotensive 341 
clinic blood pressure, and found similar ambulatory blood pressures and arterial stiffness, 342 
but elevated central systolic pressure in blacks.39 More evidence is needed to elucidate 343 
whether these findings are due to early life exposures or genetic predisposition. 344 
• Atherosclerosis 345 
Earlier studies from 1946,128 1958129 and 1963130 unanimously reported that blacks had a 346 
low prevalence of atherosclerotic heart disease, but a high hypertension rate. Since then, 347 
Tibazarwa et al.131 have pointed to “a time bomb of cardiovascular risk factors in South 348 
Africa” which may have emerged due to rapid urbanisation. Endothelial dysfunction, together 349 
with excessive mechanical stress, as seen in a hypertensive milieu, are known to increase 350 
oxidative stress and vascular inflammation, contributing to the development of 351 
atherosclerosis.132,133 In young, healthy urban black adults with normotensive clinic blood 352 
pressure we recently found significantly increased markers of endothelial activation (cellular 353 
adhesion molecules and monocyte chemoattractant protein-1), reactive oxygen species and 354 
interleukin-6, when compared to white counterparts.134 In addition, endothelial activation 355 
markers associated independently with carotid wall thickness, only in black women.134 356 
Regardless of these recent findings, sub-Saharan Africans remain far more likely to be 357 
diagnosed with heart failure, and far less likely to be diagnosed with coronary artery disease, 358 
independent of HIV infection.135,136 A possible explanation is the less atherogenic lipid profile 359 
(lower triglycerides, total and low-density lipoprotein cholesterol and higher high-density 360 
lipoprotein cholesterol) that is often seen in black compared to white populations.137 361 
However, with recent rapid epidemiological transition the proverbial time bomb is ticking. 362 
 363 
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Hypertension and end-organ damage 364 
Renal function 365 
Hypertension is the most common cause of renal dysfunction in blacks from sub-Saharan 366 
Africa, with consequent chronic kidney disease (CKD) being a major health burden.138 In 367 
Americans, the incidence of all-cause CKD was 2.7 times higher among African Americans 368 
compared to whites.139 The finer subclinical progression of renal function decline, in the form 369 
of endothelial damage and dysfunction at the glomeruli and consequent low-grade leakage 370 
of albumin, is often overlooked as a risk factor.140 Compared to whites, low-grade urinary 371 
albumin excretion was higher in sub-Saharan blacks at similar blood pressures, adjusted for 372 
age and body mass index (Figure 3).141 This supports data on African Americans showing a 373 
higher rate of kidney function decline compared to their white counterparts before the onset 374 
of CKD.139 In addition, urinary albumin excretion also seems to reflect general endothelial 375 
damage.142 In sub-Saharan Africans, we found that urinary albumin excretion associated 376 
with arterial stiffness,141 left ventricular hypertrophy (independent of blood pressure),143 and 377 
predicted all-cause and stroke mortality in non-diabetic, HIV-negative participants, 378 
independent of blood pressure and other covariates.144 379 
Cardiac structure and function 380 
Aside from congenital cardiac abnormalities, normal cardiac geometry and function are 381 
largely impacted on by sex, ethnicity and body size.145,146 The Dallas Heart Study found 382 
African Americans to have increased left ventricular mass compared to whites, along with a 383 
2-3-fold higher prevalence of left ventricular hypertrophy, independent of differences in body 384 
composition.147 Only two recent studies (Hypertension Genetic Epidemiologic Network 385 
(HyperGEN) and Coronary Artery Risk Development in Young Adults (CARDIA)) highlighted 386 
greater left ventricular size and lower left ventricular systolic and diastolic function in African 387 
American men compared to African American women, as well as white men and 388 
women.148,149 The Multi-Ethnic Study of Atherosclerosis reported on right ventricular MRI 389 
– 15 – 
 
findings, showing African Americans having lower right ventricular ejection fraction than 390 
whites, but which increased with older age. These findings suggest age-related ventricular 391 
stiffening leading to increasing right ventricular ejection fraction.150 In South Africa, at 392 
present, we lack sufficient data to investigate racial differences in cardiac structure and 393 
function, especially in the early stages of CVD development. 394 
Comorbidities 395 
Hypertensive African Americans exhibit a greater progression to end-stage renal disease, as 396 
well as heart failure, coronary heart disease, and stroke, than white counterparts.151 From a 397 
recent meta-analysis the overall prevalence of CKD was reported at 13.9% in sub-Saharan 398 
Africa, with primary hypertension being the greatest risk factor.138 Although ischemic heart 399 
disease remains rare in most African countries,152 ischemic stroke incidence is more 400 
common as found in Mozambique, Nigeria, South Africa, Sudan, and Uganda.153 Severe 401 
heart failure and secondary valvular dysfunction are reported to present in the fourth decade 402 
of life in sub-Saharan Africa,154 with asymptomatic black hypertensives subjected to left 403 
ventricular systolic dysfunction associated with male gender, diabetes mellitus, and 404 
increased left ventricular mass.155 With changing lifestyles and increasing obesity rates, it is 405 
not surprising that in 2015 the International Diabetes Federation estimated that 3.85 million 406 
South Africans between the ages of 21 and 79 years have diabetes.156 Also unique to sub-407 
Saharan Africa, the estimated incidence of new rheumatic heart disease cases aged above 408 
14 years was 23.5 cases per 100 000 per annum.157 409 
Human Immunodeficiency Virus 410 
Globally, sub-Saharan Africa is affected most by HIV and South Africa is the country with the 411 
highest number of people living with HIV accompanied by the largest antiretroviral treatment 412 
(ART) programme in the world.7 Besides cancer, CVD is the most frequent cause of death 413 
among HIV infected patients.158 The cardiovascular conditions most often reported in HIV 414 
infection in sub-Saharan Africa are pulmonary hypertension, cardiomyopathy and 415 
tuberculous pericarditis.159 Studies performed in populations from European descent found 416 
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HIV to be associated with endothelial dysfunction,160 increased arterial stiffness,161 417 
hypertension,162 the metabolic syndrome,163 renal disease164 and carotid intima-media 418 
thickness.165 It is possible that findings may differ in sub-Saharan Africa where different 419 
ethnic groups, socio-demographics, a different HIV strain and ART programmes prevail. A 420 
systematic review including 29,755 patients from sub-Saharan Africa found that, despite the 421 
high prevalence of hypertension, HIV infection was associated with lower blood pressure,166 422 
supporting our own findings.35,167 Furthermore, the prevalence of the metabolic syndrome in 423 
HIV infected populations was similar to the HIV-free population, with ART not contributing to 424 
the metabolic syndrome.167,168 In Cameroonians, an association between HIV infection, the 425 
metabolic syndrome and arterial stiffness was reported.169 However, in South Africa we 426 
found that increased endothelial activation among HIV infected blacks was not accompanied 427 
by arterial stiffness or sub-clinical atherosclerosis.170 Even after five years and with the 428 
majority of HIV infected participants (73%) on first line therapy, the carotid-femoral pulse 429 
wave velocity (8.11 vs. 8.24 m/s, p=0.45) was similar to HIV free controls.171 Collectively, our 430 
results from a single population study in South Africa indicate that HIV infection does not 431 
increase CVD risk. However, this requires verification in large longitudinal studies in different 432 
African settings.  433 
Conclusion 434 
Black populations are consistently reported to have a higher prevalence of hypertension than 435 
whites – a main reason for the higher incidence of CVD and mortality in blacks.172-174 436 
Collectively, recent findings from Africa illustrate an increased lifetime risk to hypertension 437 
from foetal life onwards, due to continuous exposure to demanding and rapidly developing 438 
socio-demographic environments. Captured within the concept of early vascular aging, black 439 
populations display early endothelial dysfunction, increased vascular tone and reactivity, 440 
microvascular structural changes, as well as increased aortic stiffness resulting in elevated 441 
central and brachial blood pressure during the day and night, when compared to whites. 442 
Together with knowledge on the contributions of sympathetic activation and abnormal renal 443 
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sodium handling, these pathophysiological adaptations result in early subclinical and clinical 444 
organ damage at younger ages. 445 
This overall enhanced understanding on determinants of blood pressure elevation in blacks 446 
encourages (a) novel approaches to assess and manage hypertension in Africa better, (b) 447 
further scientific discovery to develop more effective prevention and treatment strategies, 448 
and (c) policymakers and health advocates to collectively contribute in creating health-449 
promoting environments in Africa. 450 
Such endeavours may include firstly to launch awareness campaigns and encourage the 451 
political will to enable every adult to know their blood pressure; secondly to ensure 452 
availability of effective low cost antihypertensive medication by piggy-backing on existing 453 
HIV healthcare infrastructure; thirdly to make healthy food choices (such as fruits and 454 
vegetables) easier and to discourage unhealthy food options (such as excess calories, salt, 455 
heavily processed foods), by introducing taxes for e.g. sugar to be used to subsidise healthy 456 
foods; fourthly to promote physical activity in daily living by ensuring safe and supportive 457 
environments; and finally to prioritise resource allocation to ensure quality healthcare 458 
facilities and resources to produce culturally relevant research regarding effective preventive 459 
and therapeutic options. By employing also in Africa the latest cutting-edge research on 460 
biomarkers and polyomics proven to predict hypertension and cardiovascular outcome (such 461 
as proteomics and metabolomics), precision medicine may have the potential to lead to 462 
novel strategies in both preventing and treating hypertension in Africa. 463 
 464 
  465 
– 18 – 
 
Acknowledgements 466 
The authors of this paper, constituting the Hypertension in Africa Research Team, hereby 467 
thank the immense contributions of research support staff towards data collection, as well as 468 
input from collaborators within several challenging research projects performed in South 469 
Africa. Also, the participation of many volunteers in our studies is hereby duly acknowledged. 470 
Conflict of Interest 471 
The authors have nothing to declare.  472 
– 19 – 
 
References 473 
 1   NCD Risk Factor Collaboration (NCD_RisC). Worldwide trends in blood pressure 474 
from 1975 to 2015: a pooled analysis of 1479 population-based measurement 475 
studies with 19.1 million participants. Lancet 2016; doi: 10.1016/S0140-476 
6736(16)31919-5. 477 
 2   Ataklte F, Erqou S, Kaptoge S, Taye B, Echouffo-Tcheugui JB, Kengne AP. Burden 478 
of undiagnosed hypertension in sub-saharan Africa: a systematic review and meta-479 
analysis. Hypertension 2015;65: 291-298. 480 
 3   Hendriks ME, Rosendaal NT, Wit FW, Bolarinwa OA, Kramer B, Brals D et al. 481 
Sustained effect of health insurance and facility quality improvement on blood 482 
pressure in adults with hypertension in Nigeria: A population-based study. Int J 483 
Cardiol 2016;202: 477-484. 484 
 4   Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG et al. 485 
Clinical practice guidelines for the management of hypertension in the community a 486 
statement by the American Society of Hypertension and the International Society of 487 
Hypertension. J Hypertens 2014;32: 3-15. 488 
 5   Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation 489 
2005;112: 3562-3568. 490 
 6   Popkin BM, Adair LS, Ng SW. Global nutrition transition and the pandemic of obesity 491 
in developing countries. Nutr Rev 2012;70: 3-21. 492 
 7   Wang H, Wolock TM, Carter A, Nguyen G, Kyu HH, Gakidou E et al. Estimates of 493 
global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: 494 
the Global Burden of Disease Study 2015. Lancet HIV 2016;3: e361-e387. 495 
 8   Olsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA et al. A call to 496 
action and a lifecourse strategy to address the global burden of raised blood 497 
pressure on current and future generations: the Lancet Commission on hypertension. 498 
Lancet 2016; doi: 10.1016/S0140-6736(16)31134-5. 499 
– 20 – 
 
 9   Kagura J, Adair LS, Munthali RJ, Pettifor JM, Norris SA. Association Between Early 500 
Life Growth and Blood Pressure Trajectories in Black South African Children. 501 
Hypertension 2016;68: 1123-1131. 502 
 10   Munthali RJ, Kagura J, Lombard Z, Norris SA. Childhood adiposity trajectories are 503 
associated with late adolescent blood pressure: birth to twenty cohort. BMC Public 504 
Health 2016;16: 665. 505 
 11   Kagura J, Adair LS, Pisa PT, Griffiths PL, Pettifor JM, Norris SA. Association of 506 
socioeconomic status change between infancy and adolescence, and blood 507 
pressure, in South African young adults: Birth to Twenty Cohort. BMJ Open 2016;6: 508 
e008805. 509 
 12   Monteiro CA, Moubarac JC, Cannon G, Ng SW, Popkin B. Ultra-processed products 510 
are becoming dominant in the global food system. Obes Rev 2013;14 Suppl 2: 21-511 
28. 512 
 13   Popkin BM. Nutrition, Agriculture and the Global Food System in Low and Middle 513 
Income Countries. Food Policy 2014;47: 91-96. 514 
 14   Schram A, Labonte R, Sanders D. Urbanization and international trade and 515 
investment policies as determinants of noncommunicable diseases in Sub-Saharan 516 
Africa. Prog Cardiovasc Dis 2013;56: 281-301. 517 
 15   Hamada A, Mori M, Mori H, Muhihi A, Njelekela M, Masesa Z et al. Deterioration of 518 
traditional dietary custom increases the risk of lifestyle-related diseases in young 519 
male Africans. J Biomed Sci 2010;17 Suppl 1: S34. 520 
 16   Temple NJ, Steyn NP. Food prices and energy density as barriers to healthy food 521 
patterns in Cape Town, South Africa. J Hunger Environ Nutr 2009;4: 203-213. 522 
 17   Vorster HH, Kruger A, Wentzel-Viljoen E, Kruger HS, Margetts BM. Added sugar 523 
intake in South Africa: findings from the Adult Prospective Urban and Rural 524 
Epidemiology cohort study. Am J Clin Nutr 2014;99: 1479-1486. 525 
– 21 – 
 
 18   Swanepoel B, Schutte AE, Cockeran M, Steyn K, Wentzel-Viljoen E. Sodium and 526 
potassium intake in South Africa: an evaluation of 24-hour urine collections in a 527 
white, black, and Indian population. J Am Soc Hypertens 2016;10: 829-837. 528 
 19   Ajayi IO, Adebamowo C, Adami HO, Dalal S, Diamond MB, Bajunirwe F et al. Urban-529 
rural and geographic differences in overweight and obesity in four sub-Saharan 530 
African adult populations: a multi-country cross-sectional study. BMC Public Health 531 
2016;16: 1126. 532 
 20   Ziraba AK, Fotso JC, Ochako R. Overweight and obesity in urban Africa: A problem 533 
of the rich or the poor? BMC Public Health 2009;9: 465. 534 
 21   Kruger HS, Venter CS, Vorster HH, Margetts BM. Physical inactivity is the major 535 
determinant of obesity in black women in the North West Province, South Africa: the 536 
THUSA study. Transition and Health During Urbanisation of South Africa. Nutrition 537 
2002;18: 422-427. 538 
 22   Ware LJ, Rennie KL, Kruger HS, Kruger IM, Greeff M, Fourie CM et al. Evaluation of 539 
waist-to-height ratio to predict 5 year cardiometabolic risk in sub-Saharan African 540 
adults. Nutr Metab Cardiovasc Dis 2014;24: 900-907. 541 
 23   Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME. Obesity-induced hypertension: 542 
interaction of neurohumoral and renal mechanisms. Circ Res 2015;116: 991-1006. 543 
 24   Schutte AE, Huisman HW, van Rooyen JM, Schutte R, Malan L, Reimann M et al. 544 
Should obesity be blamed for the high prevalence rates of hypertension in black 545 
South African women? J Hum Hypertens 2008;22: 528-536. 546 
 25   Pieterse C, Schutte R, Schutte AE. Autonomic activity and leptin in Africans and 547 
whites: the SABPA study. J Hypertens 2014;32: 826-833. 548 
 26   Schutte AE, Huisman HW, Schutte R, van Rooyen JM, Malan L, Fourie CM et al. 549 
Adipokines and cardiometabolic function: How are they interlinked? Regul Pept 550 
2010;164: 133-138. 551 
– 22 – 
 
 27   Semlitsch T, Jeitler K, Hemkens LG, Horvath K, Nagele E, Schuermann C et al. 552 
Increasing physical activity for the treatment of hypertension: a systematic review 553 
and meta-analysis. Sports Med 2013;43: 1009-1023. 554 
 28   Guthold R, Ono T, Strong KL, Chatterji S, Morabia A. Worldwide variability in 555 
physical inactivity a 51-country survey. Am J Prev Med 2008;34: 486-494. 556 
 29   Draper C, Basset S, de VA, Lambert EV. Results from South Africa's 2014 Report 557 
Card on Physical Activity for Children and Youth. J Phys Act Health 2014;11 Suppl 558 
1: S98-104. 559 
 30   Assah FK, Ekelund U, Brage S, Corder K, Wright A, Mbanya JC et al. Predicting 560 
physical activity energy expenditure using accelerometry in adults from sub-Sahara 561 
Africa. Obesity (Silver Spring) 2009;17: 1588-1595. 562 
 31   WHO report on the global tobacco epidemic, 2015: Raising taxes on tobacco. 563 
Geneva: World Health Organization; 2015.  564 
 32   WHO global report on trends in prevalence of tobacco smoking. Geneva: World 565 
Health Organization; 2015.  566 
 33   Tobacco tax success story: South Africa. Washington: Campaign for Tobacco-Free 567 
Kids 2012. 2016. 568 
 34   Pasche S, Myers B. Substance misuse trends in South Africa. Hum 569 
Psychopharmacol 2012;27: 338-341. 570 
 35   Schutte AE, Schutte R, Huisman HW, van Rooyen JM, Fourie CM, Malan NT et al. 571 
Are behavioural risk factors to be blamed for the conversion from optimal blood 572 
pressure to hypertensive status in Black South Africans? A 5-year prospective study. 573 
Int J Epidemiol 2012;41: 1114-1123. 574 
 36   Zatu MC, van Rooyen JM, Kruger A, Schutte AE. Alcohol intake, hypertension 575 
development and mortality in black South Africans. Eur J Prev Cardiol 2016;23: 308-576 
315. 577 
– 23 – 
 
 37   Wamala JF, Karyabakabo Z, Ndungutse D, Guwatudde D. Prevalence factors 578 
associated with hypertension in Rukungiri district, Uganda--a community-based 579 
study. Afr Health Sci 2009;9: 153-160. 580 
 38   Pires JE, Sebastiao YV, Langa AJ, Nery SV. Hypertension in Northern Angola: 581 
prevalence, associated factors, awareness, treatment and control. BMC Public 582 
Health 2013;13: 90. 583 
 39   Maritz M, Fourie CM, van Rooyen JM, Moss SJ, Schutte AE. Large artery stiffness is 584 
associated with gamma-glutamyltransferase in young, healthy adults: The African-585 
PREDICT study. J Am Soc Hypertens 2016;10: 772-781. 586 
 40   Zatu MC, van Rooyen JM, Loots dT, Greeff M, Schutte AE. A comparison of the 587 
cardiometabolic profile of black South Africans with suspected non-alcoholic fatty 588 
liver disease (NAFLD) and excessive alcohol use. Alcohol 2015;49: 165-172. 589 
 41   Global, regional, and national comparative risk assessment of 79 behavioural, 590 
environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: 591 
a systematic analysis for the Global Burden of Disease Study 2015. Lancet 592 
2016;388: 1659-1724. 593 
 42   Oyebode O, Oti S, Chen YF, Lilford RJ. Salt intakes in sub-Saharan Africa: a 594 
systematic review and meta-regression. Popul Health Metr 2016;14: 1. 595 
 43   Charlton KE, Steyn K, Levitt NS, Zulu JV, Jonathan D, Veldman FJ et al. Diet and 596 
blood pressure in South Africa: Intake of foods containing sodium, potassium, 597 
calcium, and magnesium in three ethnic groups. Nutrition 2005;21: 39-50. 598 
 44   Graudal N, Jurgens G. The blood pressure sensitivity to changes in sodium intake is 599 
similar in Asians, Blacks and Whites. An analysis of 92 randomized controlled trials. 600 
Front Physiol 2015;6: 157. 601 
 45   Ordunez P, Kaufman JS, Benet M, Morejon A, Silva LC, Shoham DA et al. Blacks 602 
and Whites in the Cuba have equal prevalence of hypertension: confirmation from a 603 
new population survey. BMC Public Health 2013;13: 169. 604 
– 24 – 
 
 46   Muthuri SK, Oti SO, Lilford RJ, Oyebode O. Salt Reduction Interventions in Sub-605 
Saharan Africa: A Systematic Review. PLoS One 2016;11: e0149680. 606 
 47   Bertram MY, Steyn K, Wentzel-Viljoen E, Tollman S, Hofman KJ. Reducing the 607 
sodium content of high-salt foods: effect on cardiovascular disease in South Africa. S 608 
Afr Med J 2012;102: 743-745. 609 
 48   Watkins DA, Olson ZD, Verguet S, Nugent RA, Jamison DT. Cardiovascular disease 610 
and impoverishment averted due to a salt reduction policy in South Africa: an 611 
extended cost-effectiveness analysis. Health Policy Plan 2016;31: 75-82. 612 
 49   Charlton K, Ware LJ, Menyanu E, Biritwum RB, Naidoo N, Pieterse C et al. 613 
Leveraging ongoing research to evaluate the health impacts of South Africa's salt 614 
reduction strategy: a prospective nested cohort within the WHO-SAGE multicountry, 615 
longitudinal study. BMJ Open 2016;6: e013316. 616 
 50   Cois A, Ehrlich R. Analysing the socioeconomic determinants of hypertension in 617 
South Africa: a structural equation modelling approach. BMC Public Health 2014;14: 618 
414. 619 
 51   Cooper RS, Forrester TE, Plange-Rhule J, Bovet P, Lambert EV, Dugas LR et al. 620 
Elevated hypertension risk for African-origin populations in biracial societies: 621 
modeling the Epidemiologic Transition Study. J Hypertens 2015;33: 473-480. 622 
 52   Oshodi YO, Adeyemi JD, Oke DA, Seedat S. Psychiatric morbidity in hypertensives 623 
attending a cardiology outpatient clinic in West Africa. Niger J Clin Pract 2012;15: 84-624 
88. 625 
 53   Sobngwi E, Mbanya JC, Unwin NC, Porcher R, Kengne AP, Fezeu L et al. Exposure 626 
over the life course to an urban environment and its relation with obesity, diabetes, 627 
and hypertension in rural and urban Cameroon. Int J Epidemiol 2004;33: 769-776. 628 
 54   Malan L, Malan NT. Emotional Stress as a Risk for Hypertension in Sub-Saharan 629 
Africans: Are We Ignoring the Odds? Adv Exp Med Biol 2016; DOI: 630 
10.1007/5584_2016_37. 631 
– 25 – 
 
 55   Schutte AE, Ware LJ, Huisman HW, Fourie CM, Greeff M, Khumalo T et al. 632 
Psychological distress and the development of hypertension over 5 years in black 633 
South Africans. J Clin Hypertens (Greenwich ) 2015;17: 126-133. 634 
 56   Schutte AE, Schutte R, Huisman HW, van Rooyen JM, Fourie CM, Malan NT et al. 635 
Blood pressure variability is significantly associated with ECG left ventricular mass in 636 
normotensive Africans: the SABPA Study. Hypertens Res 2011;34: 1127-1134. 637 
 57   Franklin SS, O'Brien E, Staessen JA. Masked hypertension: understanding its 638 
complexity. Eur Heart J 2016; DOI: 10.1093/eurheartj/ehw502. 639 
 58   Thompson JE, Smith W, Ware LJ, Mels MC, van Rooyen JM, Huisman HW et al. 640 
Masked hypertension and its associated cardiovascular risk in young individuals: the 641 
African-PREDICT study. Hypertens Res 2016;39: 158-165. 642 
 59   Ware LJ, Rennie KL, Gafane LF, Nell TM, Thompson JE, van Rooyen JM et al. 643 
Masked Hypertension in Low-Income South African Adults. J Clin Hypertens 644 
(Greenwich ) 2016;18: 396-404. 645 
 60   Odili AN, Thijs L, Hara A, Wei FF, Ogedengbe JO, Nwegbu MM et al. Prevalence 646 
and Determinants of Masked Hypertension Among Black Nigerians Compared With a 647 
Reference Population. Hypertension 2016;67: 1249-1255. 648 
 61   Malan L, Malan NT, Wissing MP, Seedat YK. Coping with urbanization: a 649 
cardiometabolic risk? The THUSA study. Biol Psychol 2008;79: 323-328. 650 
 62   Hamer M, Malan L. Psychophysiological risk markers of cardiovascular disease. 651 
Neurosci Biobehav Rev 2010;35: 76-83. 652 
 63   Frodl T, O'Keane V. How does the brain deal with cumulative stress? A review with 653 
focus on developmental stress, HPA axis function and hippocampal structure in 654 
humans. Neurobiol Dis 2013;52: 24-37. 655 
 64   De Kock A, Malan L, Hamer M, Cockeran M, Malan NT. Defensive coping and 656 
renovascular disease risk - Adrenal fatigue in a cohort of Africans and Caucasians: 657 
The SABPA study. Physiol Behav 2015;147: 213-219. 658 
– 26 – 
 
 65   Malan L, Hamer M, Frasure-Smith N, Steyn HS, Malan NT. Cohort Profile: 659 
Sympathetic activity and Ambulatory Blood Pressure in Africans (SABPA) 660 
prospective cohort study. Int J Epidemiol 2015;44: 1814-1822. 661 
 66   Lambert GW, Ferrier C, Kaye DM, Kalff V, Kelly MJ, Cox HS et al. Monoaminergic 662 
neuronal activity in subcortical brain regions in essential hypertension. Blood Press 663 
1994;3: 55-66. 664 
 67   Grimsrud A, Stein DJ, Seedat S, Williams D, Myer L. The association between 665 
hypertension and depression and anxiety disorders: results from a nationally-666 
representative sample of South African adults. PLoS One 2009;4: e5552. 667 
 68   Grassi G, Mark A, Esler M. The sympathetic nervous system alterations in human 668 
hypertension. Circ Res 2015;116: 976-990. 669 
 69   Huisman HW, Schutte AE, Schutte R, van Rooyen JM, Fourie CM, Mels CM et al. 670 
Exploring the link between cardiovascular reactivity and end-organ damage in African 671 
and Caucasian men: the SABPA study. Am J Hypertens 2013;26: 68-75. 672 
 70   Malan L, Hamer M, Schlaich MP, Lambert GW, Harvey BH, Reimann M et al. 673 
Facilitated defensive coping, silent ischaemia and ECG left-ventricular hypertrophy: 674 
the SABPA study. J Hypertens 2012;30: 543-550. 675 
 71   Malan L, Hamer M, von KR, Schlaich MP, Reimann M, Frasure-Smith N et al. 676 
Chronic depression symptoms and salivary NOx are associated with retinal vascular 677 
dysregulation: The SABPA study. Nitric Oxide 2016;55-56: 10-17. 678 
 72   Helmer OM, Judson WE. Metabolic studies on hypertensive patients with suppressed 679 
plasma renin activity not due to hyperaldosternosm. Circulation 1968;38: 965-976. 680 
 73   Wilson DK, Bayer L, Krishnamoorthy JS, mpey-Thornhill G, Nicholson SC, Sica DA. 681 
The prevalence of salt sensitivity in an African-American adolescent population. Ethn 682 
Dis 1999;9: 350-358. 683 
 74   Tu W, Eckert GJ, Hannon TS, Liu H, Pratt LM, Wagner MA et al. Racial differences in 684 
sensitivity of blood pressure to aldosterone. Hypertension 2014;63: 1212-1218. 685 
– 27 – 
 
 75   Li R, Richey PA, DiSessa TG, Alpert BS, Jones DP. Blood aldosterone-to-renin ratio, 686 
ambulatory blood pressure, and left ventricular mass in children. J Pediatr 2009;155: 687 
170-175. 688 
 76   Rayner BL, Myers JE, Opie LH, Trinder YA, Davidson JS. Screening for primary 689 
aldosteronism--normal ranges for aldosterone and renin in three South African 690 
population groups. S Afr Med J 2001;91: 594-599. 691 
 77   Gafane LF, Schutte R, van Rooyen JM, Schutte AE. Plasma renin and 692 
cardiovascular responses to the cold pressor test differ in black and white 693 
populations: The SABPA study. J Hum Hypertens 2016;30: 346-351. 694 
 78   van Rooyen JM, Poglitsch M, Huisman HW, Mels C, Kruger R, Malan L et al. 695 
Quantification of systemic renin-angiotensin system peptides of hypertensive black 696 
and white African men established from the RAS-Fingerprint(R). J Renin Angiotensin 697 
Aldosterone Syst 2016; 1-7. 698 
 79   Rayner BL, Owen EP, King JA, Soule SG, Vreede H, Opie LH et al. A new mutation, 699 
R563Q, of the beta subunit of the epithelial sodium channel associated with low-700 
renin, low-aldosterone hypertension. J Hypertens 2003;21: 921-926. 701 
 80   Scott L, Woodiwiss AJ, Maseko MJ, Veliotes DG, Majane OH, Paiker J et al. 702 
Aldosterone-to-renin ratio and the relationship between urinary salt excretion and 703 
blood pressure in a community of African ancestry. Am J Hypertens 2011;24: 951-704 
957. 705 
 81   Huan Y, Deloach S, Keith SW, Goodfriend TL, Falkner B. Aldosterone and 706 
aldosterone: renin ratio associations with insulin resistance and blood pressure in 707 
African Americans. J Am Soc Hypertens 2012;6: 56-65. 708 
 82   Stewart AD, Millasseau SC, Dawes M, Kyd PA, Chambers JB, Ritter JM et al. 709 
Aldosterone and left ventricular hypertrophy in Afro-Caribbean subjects with low renin 710 
hypertension. Am J Hypertens 2006;19: 19-24. 711 
– 28 – 
 
 83   van Rooyen JM, Schutte AE, Huisman HW, Schutte R, Fourie CM, Malan NT et al. 712 
End-organ damage in urbanized Africans with low plasma renin levels: the SABPA 713 
study. Clin Exp Hypertens 2014;36: 70-75. 714 
 84   Hamer M, Malan L, Schutte AE, Huisman HW, van Rooyen JM, Schutte R et al. 715 
Plasma renin responses to mental stress and carotid intima-media thickness in black 716 
Africans: the SABPA study. J Hum Hypertens 2011;25: 437-443. 717 
 85   Rayner B, Ramesar R, Steyn K, Levitt N, Lombard C, Charlton K. G-protein-coupled 718 
receptor kinase 4 polymorphisms predict blood pressure response to dietary 719 
modification in Black patients with mild-to-moderate hypertension. J Hum Hypertens 720 
2012;26: 334-339. 721 
 86   Bochud M, Staessen JA, Maillard M, Mazeko MJ, Kuznetsova T, Woodiwiss A et al. 722 
Ethnic differences in proximal and distal tubular sodium reabsorption are heritable in 723 
black and white populations. J Hypertens 2009;27: 606-612. 724 
 87   van Rooyen JM, Nienaber AW, Huisman HW, Schutte AE, Malan NT, Schutte R et al. 725 
Differences in resting cardiovascular parameters in 10- to 15-year-old children of 726 
different ethnicity: the contribution of physiological and psychological factors. Ann 727 
Behav Med 2004;28: 163-170. 728 
 88   Heffernan KS, Jae SY, Wilund KR, Woods JA, Fernhall B. Racial differences in 729 
central blood pressure and vascular function in young men. Am J Physiol Heart Circ 730 
Physiol 2008;295: H2380-H2387. 731 
 89   Zaborska KE, Wareing M, Austin C. Comparisons between perivascular adipose 732 
tissue and the endothelium in their modulation of vascular tone. Br J Pharmacol 733 
2016; DOI: 10.1111/bph.13648. 734 
 90   Mulukutla SR, Venkitachalam L, Bambs C, Kip KE, Aiyer A, Marroquin OC et al. 735 
Black race is associated with digital artery endothelial dysfunction: results from the 736 
Heart SCORE study. Eur Heart J 2010;31: 2808-2815. 737 
 91   Ozkor MA, Rahman AM, Murrow JR, Kavtaradze N, Lin J, Manatunga A et al. 738 
Differences in vascular nitric oxide and endothelium-derived hyperpolarizing factor 739 
– 29 – 
 
bioavailability in blacks and whites. Arterioscler Thromb Vasc Biol 2014;34: 1320-740 
1327. 741 
 92   Glyn MC, van Rooyen JM, Schutte R, Huisman HW, Boger RH, Schwedhelm E et al. 742 
A comparison of the association between glomerular filtration and L-arginine status in 743 
HIV-infected and uninfected African men: the SAfrEIC study. J Hum Hypertens 744 
2013;27: 557-563. 745 
 93   Brewster LM, Seedat YK. Why do hypertensive patients of African ancestry respond 746 
better to calcium blockers and diuretics than to ACE inhibitors and beta-adrenergic 747 
blockers? A systematic review. BMC Med 2013;11: 141. 748 
 94   Oudman I, Kewalbansingh PV, van V, I, Zwinderman AH, Clark JF, van Montfrans 749 
GA et al. Creatine kinase is associated with failure of hypertension treatment. J 750 
Hypertens 2013;31: 1025-1031. 751 
 95   Mels CM, Schutte AE, Schutte R, Pretorius PJ, Smith W, Huisman HW et al. 8-Oxo-752 
7,8-dihydro-2'-deoxyguanosine, reactive oxygen species and ambulatory blood 753 
pressure in African and Caucasian men: the SABPA study. Free Radic Res 2014;48: 754 
1291-1299. 755 
 96   Mels CM, van ZC, Huisman HW. Cardiovascular function is not associated with 756 
creatine kinase activity in a black African population: The SABPA study. BMC 757 
Cardiovasc Disord 2016;16: 134. 758 
 97   Harrison DG, Guzik TJ, Lob HE, Madhur MS, Marvar PJ, Thabet SR et al. 759 
Inflammation, immunity, and hypertension. Hypertension 2011;57: 132-140. 760 
 98   Jones DP. Redefining oxidative stress. Antioxid Redox Signal 2006;8: 1865-1879. 761 
 99   Kruger R, Schutte R, Huisman HW, van Rooyen JM, Malan NT, Fourie CM et al. 762 
Associations between reactive oxygen species, blood pressure and arterial stiffness 763 
in black South Africans: the SABPA study. J Hum Hypertens 2012;26: 91-97. 764 
 100   van Zyl C, Huisman HW, Mels CM. Antioxidant enzyme activity is associated with 765 
blood pressure and carotid intima media thickness in black men and women: The 766 
SABPA study. Atherosclerosis 2016;248: 91-96. 767 
– 30 – 
 
 101   Schutte R, Schutte AE, Huisman HW, van Rooyen JM, Malan NT, Peter S et al. 768 
Blood glutathione and subclinical atherosclerosis in African men: the SABPA Study. 769 
Am J Hypertens 2009;22: 1154-1159. 770 
 102   Mokhaneli MC, Fourie CM, Botha S, Mels CM. The association of oxidative stress 771 
with arterial compliance and vascular resistance in a bi-ethnic population: the SABPA 772 
study. Free Radic Res 2016;50: 920-928. 773 
 103   du Plooy CS, Martha Cornelia MC, Huisman HW, Kruger R. The association of 774 
endothelin-1 with markers of oxidative stress in a biethnic South African cohort: the 775 
SABPA study. Hypertens Res 2016; DOI: 10.1038/hr.2016.128. 776 
 104   Butler CJ, Schutte R, Glyn MC, van der Westhuizen FH, Gona P, Schutte AE. 777 
Exploring the link between serum peroxides and angiogenesis in a bi-ethnic 778 
population from South Africa: the SAfrEIC study. J Am Soc Hypertens 2013;7: 267-779 
275. 780 
 105   Lammertyn L, Mels CM, Pieters M, Schutte AE, Schutte R. Ethnic-specific 781 
relationships between haemostatic and oxidative stress markers in black and white 782 
South Africans: The SABPA study. Clin Exp Hypertens 2015;37: 511-517. 783 
 106   Crowley SD. The cooperative roles of inflammation and oxidative stress in the 784 
pathogenesis of hypertension. Antioxid Redox Signal 2014;20: 102-120. 785 
 107   Schutte AE, van VD, van Rooyen JM, Huisman HW, Schutte R, Malan L et al. 786 
Inflammation, obesity and cardiovascular function in African and Caucasian women 787 
from South Africa: the POWIRS study. J Hum Hypertens 2006;20: 850-859. 788 
 108   Kruger R, Schutte R, Huisman HW, Hindersson P, Olsen MH, Eugen-Olsen J et al. 789 
NT-proBNP, C-reactive protein and soluble uPAR in a bi-ethnic male population: the 790 
SAfrEIC study. PLoS One 2013;8: e58506. 791 
 109   Botha S, Fourie CM, Schutte R, Kruger A, Schutte AE. Associations of suPAR with 792 
lifestyle and cardiometabolic risk factors. Eur J Clin Invest 2014;44: 619-626. 793 
 110   Hamer M, Malan L, Schutte AE, Huisman HW, van Rooyen JM, Schutte R et al. 794 
Conventional and behavioral risk factors explain differences in sub-clinical vascular 795 
– 31 – 
 
disease between black and Caucasian South Africans: the SABPA study. 796 
Atherosclerosis 2011;215: 237-242. 797 
 111   Botha S, Fourie CM, Schutte R, Eugen-Olsen J, Schutte AE. Soluble urokinase 798 
plasminogen activator receptor and hypertension among black South Africans after 5 799 
years. Hypertens Res 2015;38: 439-444. 800 
 112   Botha S, Fourie CM, Schutte R, Eugen-Olsen J, Pretorius R, Schutte AE. Soluble 801 
urokinase plasminogen activator receptor as a prognostic marker of all-cause and 802 
cardiovascular mortality in a black population. Int J Cardiol 2015;184: 631-636. 803 
 113   Yannoutsos A, Levy BI, Safar ME, Slama G, Blacher J. Pathophysiology of 804 
hypertension: interactions between macro and microvascular alterations through 805 
endothelial dysfunction. J Hypertens 2014;32: 216-224. 806 
 114   Cheung CY, Ikram MK, Sabanayagam C, Wong TY. Retinal microvasculature as a 807 
model to study the manifestations of hypertension. Hypertension 2012;60: 1094-808 
1103. 809 
 115   Flammer J, Konieczka K, Bruno RM, Virdis A, Flammer AJ, Taddei S. The eye and 810 
the heart. Eur Heart J 2013;34: 1270-1278. 811 
 116   Ikram MK, de Jong FJ, Vingerling JR, Witteman JC, Hofman A, Breteler MM et al. 812 
Are retinal arteriolar or venular diameters associated with markers for cardiovascular 813 
disorders? The Rotterdam Study. Invest Ophthalmol Vis Sci 2004;45: 2129-2134. 814 
 117   Ding J, Wai KL, McGeechan K, Ikram MK, Kawasaki R, Xie J et al. Retinal vascular 815 
caliber and the development of hypertension: a meta-analysis of individual participant 816 
data. J Hypertens 2014;32: 207-215. 817 
 118   McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Klein BE et al. Prediction of 818 
incident stroke events based on retinal vessel caliber: a systematic review and 819 
individual-participant meta-analysis. Am J Epidemiol 2009;170: 1323-1332. 820 
 119   Strauss M, Smith W, Schutte AE. Inter-arm Blood Pressure Difference and its 821 
Relationship with Retinal Microvascular Calibres in Young Individuals: The African-822 
PREDICT Study. Heart Lung Circ 2016;25: 855-861. 823 
– 32 – 
 
 120   Lammertyn L, Schutte AE, Smith W, Pieters M, Schutte R. Retinal vessel calibres 824 
and haemostasis in black and white South Africans: the SABPA study. J Hypertens 825 
2015;33: 2483-2490. 826 
 121   Smith W, Malan NT, Schutte AE, Schutte R, Mc MC, Vilser W et al. Retinal vessel 827 
caliber and its relationship with nocturnal blood pressure dipping status: the SABPA 828 
study. Hypertens Res 2016;39: 730-736. 829 
 122   Pienaar PR, Micklesfield LK, Gill JM, Shore AC, Gooding KM, Levitt NS et al. Ethnic 830 
differences in microvascular function in apparently healthy South African men and 831 
women. Exp Physiol 2014;99: 985-994. 832 
 123   Laurent S, Cockcroft J, Van BL, Boutouyrie P, Giannattasio C, Hayoz D et al. Expert 833 
consensus document on arterial stiffness: methodological issues and clinical 834 
applications. Eur Heart J 2006;27: 2588-2605. 835 
 124   Schutte AE, Huisman HW, Schutte R, van Rooyen JM, Malan L, Malan NT et al. 836 
Arterial stiffness profiles: investigating various sections of the arterial tree of African 837 
and Caucasian people. Clin Exp Hypertens 2011;33: 511-517. 838 
 125   Morris AA, Patel RS, Binongo JN, Poole J, Al M, I, Ahmed Y et al. Racial differences 839 
in arterial stiffness and microcirculatory function between Black and White 840 
Americans. J Am Heart Assoc 2013;2: e002154. 841 
 126   Hall JL, Duprez DA, Barac A, Rich SS. A review of genetics, arterial stiffness, and 842 
blood pressure in African Americans. J Cardiovasc Transl Res 2012;5: 302-308. 843 
 127   Mokwatsi GG, Schutte AE, Kruger R. Ethnic differences regarding arterial stiffness of 844 
6-8 year old black and white boys. Unpublished 2016. 845 
 128   Becker B. Cardio-vascular disease in the Bantu and coloured races of South Africa; 846 
hypertensive heart disease. S Afr J Med Sci 1946;11: 107-120. 847 
 129   Schwartz MB, Schamroth L, Seftel HC. The pattern of heart disease in the urbanized 848 
Johannesburg African. Med Proc 1958;4: 275-281. 849 
 130   Adelstein AM. Some aspects of cardio-vascular mortality in South Africa. Br J Prev 850 
Soc Med 1963;17: 29-40. 851 
– 33 – 
 
 131   Tibazarwa K, Ntyintyane L, Sliwa K, Gerntholtz T, Carrington M, Wilkinson D et al. A 852 
time bomb of cardiovascular risk factors in South Africa: results from the Heart of 853 
Soweto Study "Heart Awareness Days". Int J Cardiol 2009;132: 233-239. 854 
 132   Sampson UK, Engelgau MM, Peprah EK, Mensah GA. Endothelial dysfunction: a 855 
unifying hypothesis for the burden of cardiovascular diseases in sub-Saharan Africa. 856 
Cardiovasc J Afr 2015;26: S56-S60. 857 
 133   Higashi Y, Kihara Y, Noma K. Endothelial dysfunction and hypertension in aging. 858 
Hypertens Res 2012;35: 1039-1047. 859 
 134   Kriel JI, Fourie CM, Schutte AE. Monocyte Chemoattractant Protein-1 and Large 860 
Artery Structure and Function in Young Individuals: The African-PREDICT Study. J 861 
Clin Hypertens (Greenwich ) 2016. 862 
 135   Sliwa K, Wilkinson D, Hansen C, Ntyintyane L, Tibazarwa K, Becker A et al. 863 
Spectrum of heart disease and risk factors in a black urban population in South Africa 864 
(the Heart of Soweto Study): a cohort study. Lancet 2008;371: 915-922. 865 
 136   Sliwa K, Carrington MJ, Becker A, Thienemann F, Ntsekhe M, Stewart S. 866 
Contribution of the human immunodeficiency virus/acquired immunodeficiency 867 
syndrome epidemic to de novo presentations of heart disease in the Heart of Soweto 868 
Study cohort. Eur Heart J 2012;33: 866-874. 869 
 137   Goedecke JH, Utzschneider K, Faulenbach MV, Rizzo M, Berneis K, Spinas GA et 870 
al. Ethnic differences in serum lipoproteins and their determinants in South African 871 
women. Metabolism 2010;59: 1341-1350. 872 
 138   Stanifer JW, Jing B, Tolan S, Helmke N, Mukerjee R, Naicker S et al. The 873 
epidemiology of chronic kidney disease in sub-Saharan Africa: a systematic review 874 
and meta-analysis. Lancet Glob Health 2014;2: e174-e181. 875 
 139   Tarver-Carr ME, Powe NR, Eberhardt MS, LaVeist TA, Kington RS, Coresh J et al. 876 
Excess risk of chronic kidney disease among African-American versus white subjects 877 
in the United States: a population-based study of potential explanatory factors. J Am 878 
Soc Nephrol 2002;13: 2363-2370. 879 
– 34 – 
 
 140   Lioudaki E, Florentin M, Ganotakis ES, Mikhailidis DP. Microalbuminuria: a neglected 880 
cardiovascular risk factor in non-diabetic individuals? Curr Pharm Des 2013;19: 881 
4964-4980. 882 
 141   Schutte R, Schutte AE, Huisman HW, Glyn MC, van Rooyen JM, Malan NT et al. 883 
Arterial stiffness, ambulatory blood pressure and low-grade albuminuria in non-884 
diabetic African and Caucasian men: the SABPA study. Hypertens Res 2011;34: 885 
862-868. 886 
 142   Jensen JS, Borch-Johnsen K, Jensen G, Feldt-Rasmussen B. Microalbuminuria 887 
reflects a generalized transvascular albumin leakiness in clinically healthy subjects. 888 
Clin Sci (Lond) 1995;88: 629-633. 889 
 143   Schutte R, Huisman HW, Ware LJ, Mels CM, Smith W, Malan NT et al. Cornell 890 
product relates to albuminuria in hypertensive black adults independently of blood 891 
pressure: the SABPA study. J Am Soc Hypertens 2015;9: 115-122. 892 
 144   Schutte R, Schmieder RE, Huisman HW, Smith W, van Rooyen JM, Fourie CM et al. 893 
Urinary albumin excretion from spot urine samples predict all-cause and stroke 894 
mortality in Africans. Am J Hypertens 2014;27: 811-818. 895 
 145   Natori S, Lai S, Finn JP, Gomes AS, Hundley WG, Jerosch-Herold M et al. 896 
Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by 897 
age, sex, and ethnicity. AJR Am J Roentgenol 2006;186: S357-S365. 898 
 146   DeSimone G, Devereux RB, Chinali M, Roman MJ, Barac A, Panza JA et al. Sex 899 
differences in obesity-related changes in left ventricular morphology: the Strong 900 
Heart Study. J Hypertens 2011;29: 1431-1438. 901 
 147   Drazner MH, Dries DL, Peshock RM, Cooper RS, Klassen C, Kazi F et al. Left 902 
ventricular hypertrophy is more prevalent in blacks than whites in the general 903 
population: the Dallas Heart Study. Hypertension 2005;46: 124-129. 904 
 148   Kishi S, Reis JP, Venkatesh BA, Gidding SS, Armstrong AC, Jacobs DR, Jr. et al. 905 
Race-ethnic and sex differences in left ventricular structure and function: the 906 
– 35 – 
 
Coronary Artery Risk Development in Young Adults (CARDIA) Study. J Am Heart 907 
Assoc 2015;4: e001264. 908 
 149   Glasser SP, Lynch AI, Devereux RB, Hopkins P, Arnett DK. Hemodynamic and 909 
echocardiographic profiles in African American compared with White offspring of 910 
hypertensive parents: the HyperGEN study. Am J Hypertens 2014;27: 21-26. 911 
 150   Kawut SM, Lima JA, Barr RG, Chahal H, Jain A, Tandri H et al. Sex and race 912 
differences in right ventricular structure and function: the multi-ethnic study of 913 
atherosclerosis-right ventricle study. Circulation 2011;123: 2542-2551. 914 
 151   Joint National Committee on Prevention, Detection, Evaluation and Treatment of 915 
High Blood Pressure. The sixth report of the Joint National Committee on Prevention, 916 
Detection, Evaluation, and Treatment of High Blood Pressure. Bethesda, Maryland: 917 
US Department of Health and Human Services, National High Blood Pressure 918 
Education Program; 1997.  919 
 152   Sliwa K, Acquah L, Gersh BJ, Mocumbi AO. Impact of Socioeconomic Status, 920 
Ethnicity, and Urbanization on Risk Factor Profiles of Cardiovascular Disease in 921 
Africa. Circulation 2016;133: 1199-1208. 922 
 153   O'Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H et al. Global and 923 
regional effects of potentially modifiable risk factors associated with acute stroke in 924 
32 countries (INTERSTROKE): a case-control study. Lancet 2016;388: 761-775. 925 
 154   Ogah OS, Sliwa K, Akinyemi JO, Falase AO, Stewart S. Hypertensive heart failure in 926 
Nigerian Africans: insights from the Abeokuta Heart Failure Registry. J Clin 927 
Hypertens (Greenwich ) 2015;17: 263-272. 928 
 155   Ojji D, Atherton J, Sliwa K, Alfa J, Ngabea M, Opie L. Left Ventricular Systolic 929 
Dysfunction in Asymptomatic Black Hypertensive Subjects. Am J Hypertens 2015;28: 930 
924-929. 931 
 156   International Diabetes Federation. IDF Diabetes Atlas. Seventh ed. Brussels: IDF; 932 
2015. 933 
– 36 – 
 
 157   Sliwa K, Carrington M, Mayosi BM, Zigiriadis E, Mvungi R, Stewart S. Incidence and 934 
characteristics of newly diagnosed rheumatic heart disease in urban African adults: 935 
insights from the heart of Soweto study. Eur Heart J 2010;31: 719-727. 936 
 158   Giannarelli C, Klein RS, Badimon JJ. Cardiovascular implications of HIV-induced 937 
dyslipidemia. Atherosclerosis 2011;219: 384-389. 938 
 159   Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D. The burden of 939 
non-communicable diseases in South Africa. Lancet 2009;374: 934-947. 940 
 160   Arildsen H, Sorensen KE, Ingerslev JM, Ostergaard LJ, Laursen AL. Endothelial 941 
dysfunction, increased inflammation, and activated coagulation in HIV-infected 942 
patients improve after initiation of highly active antiretroviral therapy. HIV Med 943 
2013;14: 1-9. 944 
 161   Papita AM, Albu A, Fodor D, Bondor C, Itu C, Carstina D. Markers of preclinical 945 
vascular disease and left ventricular diastolic dysfunction in patients with HIV 946 
infection. Med Ultrason 2012;14: 10-18. 947 
 162   Seaberg EC, Munoz A, Lu M, Detels R, Margolick JB, Riddler SA et al. Association 948 
between highly active antiretroviral therapy and hypertension in a large cohort of men 949 
followed from 1984 to 2003. AIDS 2005;19: 953-960. 950 
 163   Paula AA, Falcao MC, Pacheco AG. Metabolic syndrome in HIV-infected individuals: 951 
underlying mechanisms and epidemiological aspects. AIDS Res Ther 2013;10: 32. 952 
 164   Szczech LA, Grunfeld C, Scherzer R, Canchola JA, van der HC, Sidney S et al. 953 
Microalbuminuria in HIV infection. AIDS 2007;21: 1003-1009. 954 
 165   Ross AC, Rizk N, O'Riordan MA, Dogra V, El-Bejjani D, Storer N et al. Relationship 955 
between inflammatory markers, endothelial activation markers, and carotid intima-956 
media thickness in HIV-infected patients receiving antiretroviral therapy. Clin Infect 957 
Dis 2009;49: 1119-1127. 958 
 166   Dillon DG, Gurdasani D, Riha J, Ekoru K, Asiki G, Mayanja BN et al. Association of 959 
HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review 960 
and meta-analysis. Int J Epidemiol 2013;42: 1754-1771. 961 
– 37 – 
 
 167   Fourie CM, van Rooyen JM, Kruger A, Schutte AE. Lipid abnormalities in a never-962 
treated HIV-1 subtype C-infected African population. Lipids 2010;45: 73-80. 963 
 168   Nguyen KA, Peer N, Mills EJ, Kengne AP. A Meta-Analysis of the Metabolic 964 
Syndrome Prevalence in the Global HIV-Infected Population. PLoS One 2016;11: 965 
e0150970. 966 
 169   Ngatchou W, Lemogoum D, Ndobo P, Yagnigni E, Tiogou E, Nga E et al. Increased 967 
burden and severity of metabolic syndrome and arterial stiffness in treatment-naive 968 
HIV+ patients from Cameroon. Vasc Health Risk Manag 2013;9: 509-516. 969 
 170   Fourie CM, Schutte AE, Smith W, Kruger A, van Rooyen JM. Endothelial activation 970 
and cardiometabolic profiles of treated and never-treated HIV infected Africans. 971 
Atherosclerosis 2015;240: 154-160. 972 
 171   Fourie CM, van Rooyen JM, Huisman HW, Mels C, Smith W, Kruger R et al. Arterial 973 
stiffness in a black South African cohort infected with the human immunodeficiency 974 
virus (HIV). Atherosclerosis 2016;252: e170. 975 
 172   Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of 976 
usual blood pressure to vascular mortality: a meta-analysis of individual data for one 977 
million adults in 61 prospective studies. Lancet 2002;360: 1903-1913. 978 
 173   Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De SG et al. Executive 979 
summary: heart disease and stroke statistics--2010 update: a report from the 980 
American Heart Association. Circulation 2010;121: 948-954. 981 
 174   Brown DW, Giles WH, Greenlund KJ. Blood pressure parameters and risk of fatal 982 
stroke, NHANES II mortality study. Am J Hypertens 2007;20: 338-341. 983 
 175   Malan L, Hamer M, Schlaich MP, Lambert G, Ziemssen T, Reimann M et al. 984 
Defensive coping facilitates higher blood pressure and early sub-clinical structural 985 
vascular disease via alterations in heart rate variability: the SABPA study. 986 
Atherosclerosis 2013;227: 391-397. 987 
  988 
– 38 – 
 
Figure Legends 989 
Figure 1: Ambulatory blood pressure profiles of black and white South African school 990 
teachers during a normal working day. 991 
Figure 2: Neuroendocrine control during acute mental stress (∆, delta change %);64,69,70,175 992 
and chronic mental stress.54,65 993 
hsTrop T, troponin T; NE:Cr, norepinephrine:creatinine ratio; HRVti, heart rate variability triangular 994 
index as a measure of overall cardiovascular risk. Adjusted for age, gender, waist circumference, 995 
physical activity, gamma-glutamyl transferase, cotinine and thyroid function for HRVti. * denotes P< 996 
0.05; and ** denotes P< 0.01. 997 
Figure 3: Albumin-to-creatinine ratio and 24h mean arterial pressure by ethnicity and 998 
category of 24h mean arterial pressure, adjusted for age and body mass index (adapted 999 
from Schutte et al.141). 1000 
Charted values are means and bars represent 95% confidence limits. * denotes P< 0.01; ns, non-1001 
significant for differences between black and white men.1002 
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